Testosterone and dehydroepiandrosterone sulphate levels and IVF/ICSI results

Gynecological Endocrinology

Volumn 25, Issue 3, 2009, Pages 194-198

  Rashidi, Batool Hossein ^a   Hormoz, Bita ^a   Shahrokh Tehraninejad, Ensiyeh ^a   Shariat, Mamak ^b   Mahdavi, Atossa ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DHEAS; IVF or ICSI results; Testosterone

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; PRASTERONE SULFATE; PROGESTERONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CONCENTRATION (PARAMETERS); CROSS-SECTIONAL STUDY; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PREGNANCY; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; ULTRASOUND;

ADULT; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; MALE; PREGNANCY; PREGNANCY RATE; PROGNOSIS; SPERM INJECTIONS, INTRACYTOPLASMIC; TESTOSTERONE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67651232427     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802582644     Document Type: Article

References (24)

1. Fratharelli JL, Peterson EH. Effect of androgen levels on IVF cycles. Fertil steril 2004;81:1713-1714.
2. Casson PR, Lindsay MS, Pisarska MD, Carsen SA, Buster JA. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum reprod 2000;15:2129-2132.
3. Weil S, Vendola K, Zhoe J, Bondy CA. Androgen and follicle stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1998;84: 2951-2956.
4. Colakoglu M. The effect of DHEAS, prolactin and testosterone hormones in female fertility and hirsutim. Clin Exp Obstet Gynecol 1986;13:34-40.
5. Labrie F, Luu-The V, Labrie C, Belanger A, Simard J, Lin SX, Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003;24:152-182.
6. Andersen CY, Lossl K. Increased intrafollicular androgen levels affect human granulose cell secretion of anti-mullerian hormone and inhibin-B. Fertil Steril 2008;89:1760-1765.
7. Bonser J, Walker J, Purohit A, Reed MJ, Potter BV, Willis DS, Franks S, Mason HD. Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepian-drosterone sulphate as a precursor for oestradiol production. J Endocrinol 2000;167:465-471.
8. Balash J, Fabregues F, Penarrubia J, Carmona F, Casamitjana R, Creus M, Manau D, Casals G, Vanrell JA. Pretreatment with transdermal testosterone may improve ovarian response to gonadotropins in poor responder IVF patients with normal basal concentration of FSH. Hum Reprod 2006;21:1884-1893.
9. Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intraovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004;10:107-117.
10. Pache TD, Fauser BC. Polycystic ovaries in female to male transsexuals. Clin Endocrinol 1993;39:702-703.
11. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S. Formation and early development of follicles in the polycystic ovary. Lancet 2003;362:1017-1021.
12. Jonard S, Robert Y, Cortet- Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries is it worth counting the follicles? Hum Reprod 2003;18: 598-603.
13. Massin N, Cedrin-Durnerin I, Galey-Fontaine J, Coussieu C, Bry-Gauillard H, Hughes JN. Is androgen application beneficial for low responders? Hum Reprod 2004;19:20-21.
14. Kjotrod SB, Sunde A, Düring V, Carlsen SM. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome. Fertil steril. In Press, corrected proof, Available online 4 March 2008.
15. Haning RV, Flood CA, Hackett RJ, Loughlin JS, McClure N, Longscope C. Metabolic clearance rate of dehydroepiandrosterone sulphate, its metabolism to testosterone, and its intrafolllicular metabolism to dehydrotestosterone, androster-one, testosterone, and dihydrotestosterone in vivo. J Clin Endocrinol Metab 1991;72:1088-1095.
16. Labrie F, Luu-The V, Lin SX, Simard J, Labrie C, El-Alfy M, Pelletier G, Belanger A. Intracrinology: the role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 2000;25:1-16.
17. Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R. Age as an independent determinant of glucose tolerance. Diabetes 1991;40:44-51.
18. Kreisberg RA. Aging, glucose metabolism, and diabetes: current concepts. Geriatrics 1987;42:67-72.
19. Moran C, Knochenhauer E, Boots LR, Azziz R. Adrenal androgen excess in hyperandrogenism: relation to age and body mass. Fertil Steril 1999;71:671-674.
20. Wild RA, Umstot ES, Andersen RN, Ranney GB, Givens JR. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol 1983;146: 602-606.
21. Carmina E, Lobo RA. Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes. J Endocrinol Invest 2007;30:111-116.
22. Rein MS, Jackson KV, Sable DB, Thomas PP, Hornstein MD. Dexamethasone during ovulation induction for IVF: a pilot study. Hum Reprod 1996;11:54-255.
23. Check JH, Nazeri A, Dietterich C. Comparison of androgen levels in conception cycle following controlled ovarian stimulation using the luteal phase gonadotropin- releasing hormone agonist protocol. Gynecol Endocrinol 1995;9:209-214.
24. Garcia-Velasco JA, Moreno L, Pacheco A, Guillen A, Duque L, Requena A, Pellicer A. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil steril 2005;84:82-87.